Concepedia

R A Hilger

RA

Statistics

Publications

4

Citations

165

H-Index

4

Active since

2003

Affiliations

West German Heart and Vascular Center Essen(Current)

Essen University Hospital

University of Duisburg-Essen

R A Hilger is an author at West German Heart and Vascular Center Essen specializing in cancer pharmacology, medicine, and pharmacology.

Publications per year

2003–2014

4

Publications

4

Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer

Heike Richly, P. Kupsch, K. J. Passage et al. · International Journal of Clinical Pharmacology and Therapeutics · 2004 · 51 citations

, , +11

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors

Sebastian Bauer, R A Hilger, Thomas Mühlenberg et al. · British Journal of Cancer · 2014 · 50 citations · Full text

, , +14

Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumors

Magdalena Henke, Heike Richly, A. Drescher et al. · International Journal of Clinical Pharmacology and Therapeutics · 2009 · 35 citations

, , +8

A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors

Heike Richly, P. Kupsch, K. J. Passage et al. · International Journal of Clinical Pharmacology and Therapeutics · 2003 · 29 citations

, , +16

1–4 of 4